You are here: Industry Insights > Mereo Biopharma

News List

After delayed IPO, Mereo gets US listing via OncoMed merger pharmaphorum
December 10, 2018
UK biotech Mereo BioPharma is merging with Californian biotech OncoMed in an all-stock deal that swells its pipeline and gives it a potential licensing deal with Celgene......
Mereo BioPharma and OncoMed propose merger pharmatimes
December 10, 2018
The transaction will create a combined business with a diversified combined portfolio of seven assets, which will result in an increased number of potential near-term catalysts with a core focus remaining
Mereo BioPharma to merge with OncoMed Pharmaceuticals pharmaceutical-technology
December 10, 2018
British pharmaceutical company Mereo BioPharma Group has announced a proposal to merge with US-based drugmaker OncoMed Pharmaceuticals.....
Mereo BioPharma's Rationale for Halting IPO Draws Skepticism biospace
April 28, 2018
UK-based Mereo BioPharma pulled its planned initial public offering (IPO) on the Nasdaq Global Market, saying market conditions were not in the best interests of its shareholders.
AstraZeneca licenses genetic disease drug to Mereo Biopharma for $5 million, becomes shareholder pharmafile
October 31, 2017
AstraZeneca has agreed to license AZD9668, its experimental drug for the treatment of alpha-1 antitrypsin deficiency, to Mereo Biopharma for an upfront cash payment of $3 million plus 490,728 shares, making a total of $5 million